Classes
Publications
- Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits2013 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways2012 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Proteomic insights into chronic anthracycline cardiotoxicity2011 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death2009 | Central Library of Charles University
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo2008 | Central Library of Charles University
- Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH)2007 | Publication without faculty affiliation
- Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits2002 | Publication without faculty affiliation
- Effect of Sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) on chronic daunorubicin toxicity in rabbits: comparison with dexrazoxane2002 | Publication without faculty affiliation
- Differences between Daunorubicin and Doxorubicin Chronic toxic Effects in Rabbits2002 | Publication without faculty affiliation
- Effects of Chelating Agent DMPS (2,3-Dimercaptopropan-1-sulphonate) on Chronic Daunorubicin Cardiotoxicity in Rabbits2000 | Faculty of Pharmacy in Hradec Králové
Loading network view...
